Agilent Technologies Inc. Buyback
OLI recorded this information on 5/28/2015
Agilent Technologies Inc.
Agilent Technologies Inc. (NYSE:A) today announced that its board of directors has approved a new share repurchase program. The 2015 Stock Repurchase Program authorizes the purchase of up to $1.14 billion of the company's common stock through and including Nov. 1, 2018.
Agilent Technologies is engaged in life sciences, diagnostics and applied chemical markets. Co.'s segments are: Life Sciences and Applied Markets Business, which provides instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products; Diagnostics and Genomics Business, which includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses; and Agilent CrossLab Business, which spans the entire lab with its consumables and services portfolio to improve customer outcomes.
Agilent Technologies SEC Filing Email Alerts Service
Open the A Page at The Online Investor »
Buy (3.09 out of 4)